Showing results (51-60 of 86) with videos related to
Sort By:
Pageof 9
Plos One|February 25, 2012
A novel classification of lung cancer into molecular subtypesLisandra West, Smruti J Vidwans, Nicholas P Campbell, et al.Oncotarget|March 25, 2014
Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancerShigeru Kawabata, Chun-Te Chiang, Junji Tsurutani, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 8, 2019
Impact of Patient Characteristics, Prior Therapy, and Sample Type on Tumor Cell Programmed Cell Death Ligand 1 Expression in Patients with Advanced NSCLC Screened for the ATLANTIC StudyAnne-Marie Boothman, Marietta Scott, Marianne Ratcliffe, et al.Molecular Cancer Therapeutics|May 10, 2011
Expression signatures of the lipid-based Akt inhibitors phosphatidylinositol ether lipid analogues in NSCLC cellsChunyu Zhang, Abdel G Elkahloun, Hongling Liao, et al.Oncogene|May 14, 2003
Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitorsRoberto Bianco, Incheol Shin, Christoph A Ritter, et al.The Journal of Experimental Medicine|October 29, 2003
Immune evasion by murine melanoma mediated through CC chemokine receptor-10Takashi Murakami, Adela R Cardones, Steven E Finkelstein, et al.The Journal of Biological Chemistry|July 17, 2007
Phosphatidylinositol ether lipid analogues that inhibit AKT also independently activate the stress kinase, p38alpha, through MKK3/6-independent and -dependent mechanismsJoell J Gills, S Sianna Castillo, Chunyu Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Identification of a highly effective rapamycin schedule that markedly reduces the size, multiplicity, and phenotypic progression of tobacco carcinogen-induced murine lung tumorsCourtney A Granville, Noel Warfel, Junji Tsurutani, et al.Cell Reports|June 17, 2014
Rapamycin prevents the development and progression of mutant epidermal growth factor receptor lung tumors with the acquired resistance mutation T790MShigeru Kawabata, José R Mercado-Matos, M Christine Hollander, et al.Carcinogenesis|December 8, 2004
Induction of preneoplastic lung lesions in guinea pigs by cigarette smoke inhalation and their exacerbation by high dietary levels of vitamins C and EEmerich S Fiala, Ock Soon Sohn, Chung-Xiou Wang, et al.Pageof 9